Nuron Biotech

company

About

Nuron Biotech develops vaccines and specialty biologics for the prevention and treatment of infectious and neurodegenerative diseases.

Details

Last Funding Type
Private Equity(PE)
Last Funding Money Raised
$22.70M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

Nuron Biotech Inc. develops specialty biologics and vaccines. Its product pipeline comprises central nervous system products, such as NU100, a recombinant human interferon beta-1b for the treatment of relapsing remitting multiple sclerosis; wound healing products, including NU200, a recombinant human epidermal growth factor product for healing diabetic foot ulcers and burns; and HibTITER, a conjugate vaccine. The company was founded in 2010 and is based in Exton, Pennsylvania.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$102.70M
Nuron Biotech has raised a total of $102.70M in funding over 2 rounds. Their latest funding was raised on Feb 12, 2014 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 12, 2014 Private Equity(PE) $22.70M 1 Detail
Dec 26, 2012 Private Equity(PE) $80M 1 HealthCare Royalty Partners Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Nuron Biotech is funded by 1 investors. HealthCare Royalty Partners are the most recent investors.
Investor Name Lead Investor Funding Round
HealthCare Royalty Partners Private Equity(PE)

Employee Profiles

Number of Employee Profiles
1
Nuron Biotech has 1 current employee profiles, including Board member Gregory B. Brown, MD
Board member